243 related articles for article (PubMed ID: 31633065)
1. Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease.
de Oliveira GAP; Silva JL
Commun Biol; 2019; 2():374. PubMed ID: 31633065
[TBL] [Abstract][Full Text] [Related]
2. Familial Parkinson disease mutations influence α-synuclein assembly.
Ono K; Ikeda T; Takasaki J; Yamada M
Neurobiol Dis; 2011 Sep; 43(3):715-24. PubMed ID: 21684335
[TBL] [Abstract][Full Text] [Related]
3. Wild-type α-synuclein inherits the structure and exacerbated neuropathology of E46K mutant fibril strain by cross-seeding.
Long H; Zheng W; Liu Y; Sun Y; Zhao K; Liu Z; Xia W; Lv S; Liu Z; Li D; He KW; Liu C
Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33972418
[TBL] [Abstract][Full Text] [Related]
4. Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs.
Boyer DR; Li B; Sun C; Fan W; Sawaya MR; Jiang L; Eisenberg DS
Nat Struct Mol Biol; 2019 Nov; 26(11):1044-1052. PubMed ID: 31695184
[TBL] [Abstract][Full Text] [Related]
5. Structures and free energy landscapes of the A53T mutant-type α-synuclein protein and impact of A53T mutation on the structures of the wild-type α-synuclein protein with dynamics.
Coskuner O; Wise-Scira O
ACS Chem Neurosci; 2013 Jul; 4(7):1101-13. PubMed ID: 23607785
[TBL] [Abstract][Full Text] [Related]
6. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
Sahay S; Ghosh D; Singh PK; Maji SK
Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
[TBL] [Abstract][Full Text] [Related]
7. A triple-emission fluorescent probe reveals distinctive amyloid fibrillar polymorphism of wild-type alpha-synuclein and its familial Parkinson's disease mutants.
Celej MS; Caarls W; Demchenko AP; Jovin TM
Biochemistry; 2009 Aug; 48(31):7465-72. PubMed ID: 19586054
[TBL] [Abstract][Full Text] [Related]
8. Structural features of α-synuclein amyloid fibrils revealed by Raman spectroscopy.
Flynn JD; McGlinchey RP; Walker RL; Lee JC
J Biol Chem; 2018 Jan; 293(3):767-776. PubMed ID: 29191831
[TBL] [Abstract][Full Text] [Related]
9. Library-Derived Peptide Aggregation Modulators of Parkinson's Disease Early-Onset α-Synuclein Variants.
Watt KJC; Meade RM; Williams RJ; Mason JM
ACS Chem Neurosci; 2022 Jun; 13(12):1790-1804. PubMed ID: 35613323
[TBL] [Abstract][Full Text] [Related]
10. Distinct Effects of Familial Parkinson's Disease-Associated Mutations on α-Synuclein Phase Separation and Amyloid Aggregation.
Xu B; Fan F; Liu Y; Liu Y; Zhou L; Yu H
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238596
[TBL] [Abstract][Full Text] [Related]
11. Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy.
Bodner CR; Maltsev AS; Dobson CM; Bax A
Biochemistry; 2010 Feb; 49(5):862-71. PubMed ID: 20041693
[TBL] [Abstract][Full Text] [Related]
12. A glimpse into the structural properties of α-synuclein oligomers.
Santos J; Pallarès I; Ventura S
Biofactors; 2024; 50(3):439-449. PubMed ID: 38063360
[TBL] [Abstract][Full Text] [Related]
13. Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillation.
Bickle L; Hopwood JJ; Karageorgos L
Biochim Biophys Acta Proteins Proteom; 2017 Mar; 1865(3):261-273. PubMed ID: 28007442
[TBL] [Abstract][Full Text] [Related]
14. Different Effects of α-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements.
Ruf VC; Nübling GS; Willikens S; Shi S; Schmidt F; Levin J; Bötzel K; Kamp F; Giese A
ACS Chem Neurosci; 2019 Mar; 10(3):1649-1659. PubMed ID: 30605594
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice.
Rutherford NJ; Dhillon JS; Riffe CJ; Howard JK; Brooks M; Giasson BI
Hum Mol Genet; 2017 Dec; 26(24):4906-4915. PubMed ID: 29036344
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of enhanced aggregation and fibril formation of Parkinson's disease-related variants of α-synuclein.
Ohgita T; Namba N; Kono H; Shimanouchi T; Saito H
Sci Rep; 2022 Apr; 12(1):6770. PubMed ID: 35474118
[TBL] [Abstract][Full Text] [Related]
17. Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein.
Leitao A; Bhumkar A; Hunter DJB; Gambin Y; Sierecki E
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364143
[TBL] [Abstract][Full Text] [Related]
18. NMR unveils an N-terminal interaction interface on acetylated-α-synuclein monomers for recruitment to fibrils.
Yang X; Wang B; Hoop CL; Williams JK; Baum J
Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33903234
[TBL] [Abstract][Full Text] [Related]
19. A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid Binding.
Meade RM; Watt KJC; Williams RJ; Mason JM
J Mol Biol; 2021 Dec; 433(24):167323. PubMed ID: 34695381
[TBL] [Abstract][Full Text] [Related]
20. A sensitive assay reveals structural requirements for α-synuclein fibril growth.
Dhavale DD; Tsai C; Bagchi DP; Engel LA; Sarezky J; Kotzbauer PT
J Biol Chem; 2017 Jun; 292(22):9034-9050. PubMed ID: 28373279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
